Terragen Holdings Ltd · ASX:TGH
Terragen — Q2 2020 Earnings Presentation
13 slides from Terragen's earnings presentation, Aug 3, 2020
Slide 1: ASX Announcement: Investor Presentation – June 2020 Quarterly Activities Report
ASX Announcement For personal use only For immediate release 3 August 2020 Investor Presentation – June 2020 Quarterly Activities Report Terragen Holdings Limited (“Terragen”) (ASX:TGH) refers to the attached Investor Presentation that provides an overview of Terragen’s June 2020 Quarterly Activitie
Slide 2: Investor Presentation – June 2020 Quarterly Activities Report
For personal use only Terragen Holdings Limited ASX:TGH Investor Presentation – June 2020 Quarterly Activities Report
Slide 3: Disclaimer
Disclaimer The following disclaimer applies to this investor presentation (Presentation) and you are therefore advised to read this disclaimer carefully before reading or making any other For personal use only use of this Presentation or any information contained in this Presentation. By accepting t
Slide 4: Presenters
Presenters For personal use only Travis Dillon Jim Cooper Stephen Kelly Board Chair Managing Director & Chief Financial Officer Chief Executive Officer 0415 719 695 0417 321 145 stephenk@terragen.com.au jimc@terragen.com.au Slide 3
Slide 5: About Terragen
About Terragen For personal use only • An agricultural company manufacturing and selling biological products to farmers • Mylo® - a feed supplement for animals, such as dairy cows, and Great Land®, a soil conditioner • ASX listing in late 2019, Terragen is proudly Australian • Started scientific res
Slide 6: Sales Results
For personal use only Sales Results Slide 5
Slide 7: Cash on hand at June 2020
Cash on hand at 30 June 2020 $16.377m Use of funds table below (from Appendix 4C) For personal use only Slide 6
Slide 8: Terragen Products
For personal use only Terragen Products 120 Measured in *1000 cells/ml Slide 7
Slide 9: Terragen's Scientific Heritage and Capability
For personal use only Terragen’s Scientific Heritage and Capability ❑An in-house team of 12 highly qualified scientists supports Terragen’s research and innovation ❑In addition to scientific research and development, there is a Quality Assurance function within Terragen which approves the quality of
Slide 10: Focus on Dairy Market
For personal use only Focus on Dairy Market Addressable market of dairy cows Australia 1.44 million milking cows Victoria 1.1 million milking cows New Zealand 4.96 million milking cows Slide 9
Slide 11: Terragen's Sales Process
Terragen’s Sales Process For personal use only • Highly experienced in-house sales team; expertise in biological products and with extensive farmer networks • A large agency network with 87 agents including Nutrien, Elders, Murray Goulburn and smaller boutique agents • Marketing to the dairy industr
Slide 12: Market Trends
Market Trends For personal use only Biological products are now becoming accepted in mainstream agriculture Mylo® was initially targeted at calves but the focus is now on mature dairy cows Whole of farm sales of Mylo® and Great Land® Good rainfall in south-eastern Australia is supporting market conf
Slide 13: In FY21 …
In FY21 … For personal use only Focus for FY21 is to build sales in the Australian dairy market Terragen will also build its emerging sales network in New Zealand and grow sales there Research and development will continue within Terragen, where a number of product initiatives are being developed A